Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07668713 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FEcal tranSplantation in HidradeniTIs suppuratiVA : a piLot Study

Study acronym: FESTIVAL
StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The medical and surgical treatment of hidradenitis suppurativa (HS) remains difficult to date. The search for new therapies for HS is a major challenge. The pathophysiology of HS, the similarities with Crohn's disease and the data in the literature suggest a role for the digestive flora in HS. The role of the intestinal microbiota has now been clearly demonstrated in the pathophysiology of chronic inflammatory bowel disease (IBD), and is suspected in many other diseases. Fecal microbiota transplantation (FMT) is the gold-standard treatment for recurrent Clostridioides Difficile infection, and is being investigated in a wide range of conditions. Our hypothesis is that FMT would improve inflammatory lesions of HS by modifying patients' digestive microbiota. Translated with DeepL.com (free version)
Trial Details
NCT Number NCT07668713
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions
(from sponsor)		 Hidradenitis Suppurativa (HS), Fecal Microbiota Transplantation (FMT)
Related terms Hidradenitis Suppurativa
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov